Amundi Rx Sight, Inc. Transaction History
Amundi
- $275 Billion
- Q1 2025
A detailed history of Amundi transactions in Rx Sight, Inc. stock. As of the latest transaction made, Amundi holds 50 shares of RXST stock, worth $788. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 21
138.1%
Holding current value
$788
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RXST
# of Institutions
202Shares Held
34.5MCall Options Held
269KPut Options Held
8.5K-
Ra Capital Management, L.P. Boston, MA3.74MShares$59 Million1.96% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$37.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.39MShares$37.7 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.18MShares$34.4 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.77MShares$27.9 Million0.08% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $436M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...